These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6406460)

  • 1. Failure of bupropion to affect prolactin or growth hormone in man.
    Whiteman PD; Peck AW; Fowle AS; Smith PR
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):209-10. PubMed ID: 6406460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion fails to affect plasma prolactin and growth hormone in normal subjects.
    Whiteman PD; Peck AW; Fowle AS; Smith P
    Br J Clin Pharmacol; 1982 May; 13(5):743-5. PubMed ID: 6805494
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychopharmacology of bupropion in normal volunteers.
    Peck AW; Hamilton M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):202-5. PubMed ID: 6406458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of bupropion to affect tyramine response in man.
    Fowle AS; Peck AW; Rogers HJ; Spector RG
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):211. PubMed ID: 6406461
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of bupropion HCl (Wellbatrin), a novel antidepressant, on plasma levels of prolactin and growth hormone in man and rat.
    Stern WC; Rogers J; Fang V; Meltzer H
    Life Sci; 1979 Nov; 25(20):1717-24. PubMed ID: 316848
    [No Abstract]   [Full Text] [Related]  

  • 6. Bupropion: clinical assay for amphetamine-like abuse potential.
    Griffith JD; Carranza J; Griffith C; Miller LL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):206-8. PubMed ID: 6406459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of bupropion on body weight.
    Harto-Truax N; Stern WC; Miller LL; Sato TL; Cato AE
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):183-6. PubMed ID: 6406454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion in depression: a tri-center placebo-controlled study.
    Pitts WM; Fann WE; Halaris AE; Dressler DM; Sajadi C; Snyder S; Ilaria RL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):95-100. PubMed ID: 6406473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bupropion in hospitalized depressed patients.
    Merideth CH; Feighner JP
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):85-7. PubMed ID: 6406471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers.
    Elman I; Lukas SE
    Addict Behav; 2005 May; 30(4):859-64. PubMed ID: 15833589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two multicenter studies of the antidepressant effects of bupropion HCl versus placebo.
    Stern WC; Harto-Truax N
    Psychopharmacol Bull; 1980 Jul; 16(3):43-6. PubMed ID: 6773096
    [No Abstract]   [Full Text] [Related]  

  • 12. Methodologic approach to adverse events applied to bupropion clinical trials.
    Cato AE; Cook L; Starbuck R; Heatherington D
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):187-90. PubMed ID: 6406455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the effects of bupropion SR on mood dimensions of depression.
    Tomarken AJ; Dichter GS; Freid C; Addington S; Shelton RC
    J Affect Disord; 2004 Mar; 78(3):235-41. PubMed ID: 15013248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of bupropion, a new antidepressant drug, and alcohol and their interaction in man.
    Hamilton MJ; Bush MS; Peck AW
    Eur J Clin Pharmacol; 1984; 27(1):75-80. PubMed ID: 6436033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.
    Zdravkovic M; Søgaard B; Ynddal L; Christiansen T; Agersø H; Thomsen MS; Falch JE; Ilondo MM
    Growth Horm IGF Res; 2000 Aug; 10(4):193-8. PubMed ID: 11032702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.
    Smarius LJ; Jacobs GE; Hoeberechts-Lefrandt DH; de Kam ML; van der Post JP; de Rijk R; van Pelt J; Schoemaker RC; Zitman FG; van Gerven JM; Gijsman HJ
    J Psychopharmacol; 2008 Jun; 22(4):426-33. PubMed ID: 18308795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of plasma bupropion and its relationship to therapeutic effect.
    Fogel P; Mamer OA; Chouinard G; Farrell PG
    Biomed Mass Spectrom; 1984 Dec; 11(12):629-32. PubMed ID: 6442168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of bupropion-associated delirium.
    Dager SR; Heritch AJ
    J Clin Psychiatry; 1990 Jul; 51(7):307-8. PubMed ID: 2114399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man.
    Ur E; Wright DM; Bouloux PM; Grossman A
    Br J Pharmacol; 1997 Mar; 120(5):781-4. PubMed ID: 9138682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical profile of the novel antidepressant bupropion.
    Stern WC; Harto-Truax N; Rogers J; Miller L
    Adv Biochem Psychopharmacol; 1982; 32():21-34. PubMed ID: 6807060
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.